Healmusz Fast Natural Wart Removal

Description

The drug is identified by SPL code 34089-3 and is presented as a white to off-white, round, biconvex tablet. The tablet is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. Inactive ingredients consist of lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the removal of common warts characterized by a rough, cauliflower-like appearance.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and soaking in warm water for approximately 5 minutes may facilitate this process. After cleansing, the area must be dried completely. A small amount of the medication should then be applied to cover each wart, ensuring that it is allowed to dry. This application should be repeated twice daily as necessary, with treatment continuing for a maximum duration of 12 weeks.

Contraindications

Use is contraindicated in the following situations:

Application on irritated or infected skin, or areas exhibiting redness is prohibited due to the potential for exacerbating the condition.

Patients with diabetes or poor blood circulation should not use this product, as it may pose an increased risk of complications.

Additionally, the product should not be applied to birthmarks, warts with hair growth, or moles, as these conditions may lead to adverse reactions.

Warnings and Precautions

For external use only; contact with the eyes must be strictly avoided. In the event of accidental exposure to the eyes, it is imperative to rinse thoroughly with water for a minimum of 15 minutes. Additionally, inhalation of vapors should be avoided to prevent respiratory irritation.

In cases of ingestion, immediate medical assistance should be sought, or the individual should contact a Poison Control Center without delay. This precaution is critical to ensure the safety and well-being of the patient.

Healthcare professionals should advise patients to discontinue use and consult a physician if any discomfort persists. Monitoring for adverse reactions is essential to ensure patient safety and effective management of any potential side effects.

Side Effects

Patients using this product should be aware that it is for external use only. Care should be taken to avoid contact with the eyes; in the event of contact, it is recommended to rinse the eyes with water for 15 minutes. Additionally, patients should avoid inhaling vapors associated with the product.

In the event that discomfort persists, patients are advised to stop using the product and consult a healthcare professional. This precaution is important to ensure the safety and well-being of the user.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Healmusz Fast Natural Wart Removal (salicylic acid 17% fast natural wart removal). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be closely monitored to ensure that the medication is kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is essential to evaluate the potential risks and benefits in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions recommended for individuals with compromised liver function. It is advised that healthcare professionals exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be considered as part of standard clinical practice.

Overdosage

In the absence of specific details regarding overdosage for this medication (SPL code 34088-5), it is essential for healthcare professionals to remain vigilant and consider general principles of management in cases of suspected overdosage.

Recommended Actions In the event of an overdosage, healthcare providers should initiate appropriate supportive measures. This may include monitoring the patient's vital signs and providing symptomatic treatment as necessary. It is advisable to contact a poison control center or seek expert consultation for guidance tailored to the specific circumstances of the overdosage.

Potential Symptoms While specific symptoms associated with overdosage of this medication are not detailed, healthcare professionals should be aware that overdosage can lead to a range of adverse effects. Symptoms may vary based on the pharmacological properties of the drug and the individual patient's response.

Management Procedures Management of overdosage should be guided by the clinical presentation of the patient. Supportive care is paramount, and interventions may include the administration of activated charcoal if the patient presents within a suitable timeframe. Continuous monitoring and reassessment of the patient's condition are critical to ensure timely intervention and to mitigate potential complications.

In summary, while specific overdosage information is not provided, healthcare professionals should apply general overdosage management principles and remain alert to the potential for adverse effects.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical help or contact a Poison Control Center if the product is swallowed.

Patients should be informed that the product should not be applied to irritated or infected skin, or to areas that are reddened. Additionally, it should not be used on birthmarks, warts with hair growth, or moles.

Providers should counsel patients to discontinue use and consult a doctor if discomfort persists after application.

For patients who are pregnant or breastfeeding, it is essential to recommend consulting a health professional before using the product.

Storage and Handling

The product is supplied in a tube format, with specific handling and storage requirements to ensure its integrity and efficacy. It should be stored at room temperature, away from direct light exposure. To maintain the product's quality, it is essential to keep the tube tightly closed when not in use. Additionally, the product should be discarded after opening to prevent any potential degradation or contamination.

Additional Clinical Information

The product is administered topically, with a recommendation to apply a small amount to cover each wart, allowing it to dry. This application should be repeated twice daily as needed, for a duration of up to 12 weeks. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Healmusz Fast Natural Wart Removal, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)